Literature DB >> 33944759

A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.

H Sunpath1, S Pillay, T Hatlen, R A Murphy, V C Marconi, M-Y S Moosa, K Naidoo, M J Siedner.   

Abstract

BACKGROUND: Identification of patients on antiretroviral therapy (ART) with virological failure (VF) and the response in the public health sector remain significant challenges. We previously reported improvement in routine viral load (VL) monitoring after ART commencement through a health system-strengthening, nurse-led 'VL champion' programme as part of a multidisciplinary team in three public sector clinics in Durban, South Africa.
OBJECTIVES: To report on the impact of the VL champion model adapted to identify, support and co-ordinate the management of individuals with VF on first-line ART in a setting with limited electronic-based record capacity.
METHODS: We evaluated the VL champion model using a controlled before-after study design. A paper-based tool, the 'high VL register', was piloted under the supervision of the VL champion to improve data management, monitoring of counselling support, and enacting of clinical decisions. We abstracted chart and electronic data (TIER.net) for eligible individuals with VF in the year before and after implementation of the programme, and compared outcomes for individuals during these periods. Our primary outcome was successful completion of the VF pathway, defined as a repeat VL <1 000 copies/mL or a change to second-line ART within 6 months of VF. In a secondary analysis, we assessed the completion of each step in the pathway.
RESULTS: We identified 60 and 56 individuals in the pre-intervention and post-intervention periods, respectively, with VF who met the inclusion criteria. Sociodemographic and clinical characteristics were similar between the periods. Repeat VL testing was completed in 61.7% and 57.8% of individuals in these two groups, respectively. We found no difference in the proportion achieving our primary outcome in the pre- and post-intervention periods: 11/60 (18.3%; 95% confidence interval (CI) 9 - 28) and 15/56 (22.8%; 95% CI 15 - 38), respectively (p=0.28). In multivariable logistic regression models adjusted for potential confounding factors, individuals in the post-intervention period had a non-significant doubling of the odds of achieving the primary outcome (adjusted odds ratio 2.07; 95% CI 0.75 - 5.72). However, there was no difference in the rates of completion of each step along the first-line VF cascade of care.
CONCLUSIONS: This enhanced intervention to improve VF in the public sector using a paper-based data management system failed to achieve significant improvements in first-line VF management over the standard of care. In addition to interventions that better address patient-centred factors that contribute to VF, we believe that there are substantial limitations to and staffing requirements involved in the ongoing utilisation of a paper-based tool. A prioritisation is needed to further expand and upgrade the electronic medical record system with capabilities for prompting staff regarding patients with missed visits and critical laboratory results demonstrating VF.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33944759      PMCID: PMC8100970          DOI: 10.7196/SAMJ.2021.v111i4.15432

Source DB:  PubMed          Journal:  S Afr Med J


  23 in total

1.  Targeting the third '90': introducing the viral load champion.

Authors:  H Sunpath; T J Hatlen; K K Naidu; P Msimango; R N Adams; M-Y S Moosa; V C Marconi; R A Murphy; R T Gandhi; S Pillay; M Siedner; K Naidoo
Journal:  Public Health Action       Date:  2018-12-21

2.  Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Authors:  Victoria Johnston; Katherine L Fielding; Salome Charalambous; Gavin Churchyard; Andrew Phillips; Alison D Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

3.  Adherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.

Authors:  Funeka Bango; John Ashmore; Lynne Wilkinson; Gilles van Cutsem; Susan Cleary
Journal:  Trop Med Int Health       Date:  2016-07-10       Impact factor: 2.622

4.  Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Authors:  Vincent C Marconi; Henry Sunpath; Zhigang Lu; Michelle Gordon; Kofi Koranteng-Apeagyei; Jane Hampton; Steve Carpenter; Janet Giddy; Douglas Ross; Helga Holst; Elena Losina; Bruce D Walker; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

5.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

6.  Clinical outcomes after first-line HIV treatment failure in South Africa: the next cascade of care.

Authors:  C C Iwuji; M Shahmanesh; O Koole; K Herbst; D Pillay; M J Siedner; K Baisley
Journal:  HIV Med       Date:  2020-06-03       Impact factor: 3.094

7.  Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.

Authors:  Victor Ssempijja; Gertrude Nakigozi; Larry Chang; Ron Gray; Maria Wawer; Anthony Ndyanabo; Jingo Kasule; David Serwadda; Barbara Castelnuovo; Anja Van't Hoog; Steven James Reynolds
Journal:  BMC Infect Dis       Date:  2017-08-22       Impact factor: 3.090

8.  Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs.

Authors:  Sarah Swannet; Tom Decroo; Sheila M T L de Castro; Caroline Rose; Ruggero Giuliani; Lucas Molfino; Ana W Torrens; Walter S E D Macueia; Sharon Perry; Tony Reid
Journal:  Int Health       Date:  2017-07-01       Impact factor: 2.473

9.  Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.

Authors:  Amir Shroufi; Gilles Van Cutsem; Valentina Cambiano; Loveleen Bansi-Matharu; Kristal Duncan; Richard A Murphy; David Maman; Andrew Phillips
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

10.  Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis.

Authors:  Mario Cruciani; Saverio G Parisi
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

View more
  1 in total

1.  Detection of HIV Virologic Failure and Switch to Second-Line Therapy: A Systematic Review and Meta-analysis of Data From Sub-Saharan Africa.

Authors:  Kerlly J Bernabé; Mark Siedner; Alexander C Tsai; Vincent C Marconi; Richard A Murphy
Journal:  Open Forum Infect Dis       Date:  2022-03-09       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.